Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/04/2003US20030223972 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/04/2003US20030223971 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/04/2003US20030223968 Protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003CA2704273A1 Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
12/04/2003CA2505598A1 A bank of stem cells for transplantation
12/04/2003CA2505592A1 Generation of histocompatible tissues using nuclear transplantation
12/04/2003CA2494134A1 Treatment for diabetes
12/04/2003CA2487858A1 Methods, compositions, and growth and differentiation factors for insulin-producing cells
12/04/2003CA2487452A1 A method for generating antigen-presenting cells
12/04/2003CA2487351A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003CA2487322A1 Animal genotyping method
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2486578A1 Detection of secreted polypeptides
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2486173A1 Cell delivery fluid for prevention of cell settling in delivery system
12/04/2003CA2485816A1 Vaccines
12/04/2003CA2485732A1 Generation and selection of protein library in silico
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2485332A1 Cytokine-free growth and maintenance of progenitor cells
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003CA2480011A1 Dentritic cell nodes
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1367127A1 A method for production of plants with suppressed photorespiration and improved CO2 fixation
12/03/2003EP1367126A1 Novel vectors for animal cells and utilization thereof
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1367119A2 Methods of culturing, storing, and inducing differentiation in cells, instrument for use in the methods, method of using the instrument, and medical biomaterial
12/03/2003EP1366772A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same
12/03/2003EP1366366A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366148A2 Differentiation of stem cells to pancreatic endocrine cells
12/03/2003EP1366146A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
12/03/2003EP1366145A1 Bio-reactor for tissue cultivated in the form of a thin layer and uses thereof
12/03/2003EP1366144A2 A device for preparing cells
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety
12/03/2003EP1366059A2 Methods and compositions for modulating gluconeogenesis using pgc-1
12/03/2003EP1365915A1 Polymer gel contact masks and methods and molds for making same
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365793A2 Treatment of inflammatory bowel disease using growth factors
12/03/2003EP1365784A1 Methods and devices for tissue repair
12/03/2003EP1365783A1 Myb-transformed blood cells and their use for active ingredient screening
12/03/2003EP1365726A2 Method for evaluating therapeutic efficacy
12/03/2003EP1365645A2 Transgenic mice containing targeted gene disruptions
12/03/2003EP1037643B1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
12/03/2003EP0980270B1 Dermal sheath tissue in wound healing
12/03/2003EP0859830B1 Growth of adult pancreatic islet cells with laminin 5
12/03/2003EP0832196B1 Immortalization and disimmortalization of cells
12/03/2003EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003EP0631629B1 Fungus-responsive chimaeric gene
12/03/2003CN2589483Y Air lifting reactor
12/03/2003CN1460123A Method for in vitro selection of potato clones resistant to blackspot bruising and potatoes produced therefrom
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/03/2003CN1459504A Flowerless gene and pure nutrition growth plant type establishment and its established technical system
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129667C Autoimmune cell for treating tumor and its preparing process
12/03/2003CN1129666C Human tissue inhibitor of metalloproteinase -4
12/03/2003CN1129456C New artificial microsaccular adrenal gland organ and its use
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6657003 Cell adhesion solution
12/02/2003US6656908 Pesticidal toxins and nucleotide sequences which encode these toxins
12/02/2003US6656746 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders
12/02/2003US6656743 Human choline acetyltransferase
12/02/2003US6656733 E.g., sodium alginate and carboxymethylcellulose
12/02/2003US6656731 Nucleic acid catalysts with endonuclease activity
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656727 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
12/02/2003US6656726 Viral expression vectors
12/02/2003US6656720 For use in vaccines
12/02/2003US6656719 Serum-free, low-protein media for rotavirus vaccine production
12/02/2003US6656717 Cyclic AMP phosphodiesterase isoforms and methods of use
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656715 Isolated nucleic acid encoding a polypeptide which catalyzes the oxidation of o-dianisidine; useful in replacing synthetic organic chemistry reactions to make active intermediates or products, such as pesticides and antibiotics
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656708 Splice variant; expression vectors
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 1827